✦ LIBER ✦

Treatment of chronic hepatitis C in hemodialysis patients

✍ Scribed by Teresa Casanovas

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 43 KB
Volume: 49
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.22923

No coin nor oath required. For personal study only.

✦ Synopsis

Our algorithm cannot be directly applied to other populations directly because clinical backgrounds differ among countries. However, we think that our study is applicable on a global scale because it has clearly shown that a combination of viral and host factors is effective for predicting the response to peg-interferon alpha and ribavirin combination therapy.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis C in hemo

Treatment of chronic hepatitis C in hemodialysis patients

✍ Marina Berenguer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB 👁 1 views

Hepatitis C virus (HCV) infection is especially problematic in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis. Rates of HCV infection are higher among hemodialysis patients than in the general population, and several routes of transmission are thought to stem from the d

Risk of hepatitis C virus infection in h

Risk of hepatitis C virus infection in hemodialysis patients

✍ Maurizio D'Aquino; Lucio Michieletto; Diego Tempesta; Corrado Pipan 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views

DDB treatment of patients with chronic h

DDB treatment of patients with chronic hepatitis

✍ Roman Huber; Birgit Hockenjos; Hubert E. Blum 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 1 views

We report 13 patients (10 with chronic hepatitis C, 1 with chronic hepatitis B, 2 with nonalcoholic steatohepatitis) with persistently elevated alanine aminotransferase (ALT) levels who were treated with dimethyl-4,4-dimethoxy-5,6,5,6-dimethylenedioxybiphenyl-2,2 dicarboxylate (DDB). ALT rapidly nor

Immune response in chronic hepatitis C–i

Immune response in chronic hepatitis C–infected patients undergoing interferon treatment

✍ Antonietta Cargnel; Guido Gubertini; Carlo Magnani; Simona Bosis; Fulvia Colombo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 1 views

The findings of Mason et al. 1 on diabetes mellitus and hepatitis C are similar to our own, reported at the 8th European Congress of Clinical Microbiology and Infectious Diseases. 2 In our study, diabetes was found in 34.7% and 2.7% of chronic hepatitis C and chronic hepatitis B patients, respective

Hepatitis B vaccination in patients with

Hepatitis B vaccination in patients with chronic hepatitis C

✍ Lee, Shou-Dong; Chan, Cho-Yu; Yu, May-Ing; Lu, Rei-Hwa; Chang, Full-Young; Lo, K 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Re-treatment with interferon alfa of pat

Re-treatment with interferon alfa of patients with chronic hepatitis C

✍ Wan-Cheng Chow; Nathalie Boyer; Michele Pouteau; Corinne Castelnau; Michele Mart 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res